← Eichor
Condition: Colorectal Liver Metastases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Colorectal Liver Metastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Pa
Phase 3 · 60 location(s) · ECOG-ACRIN Cancer Research Group · NCT05863195
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT05185245
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT02838836
TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases
NA · 1 location(s) · Niguarda Hospital · NCT07607873
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Phase N/A · 1 location(s) · Mu-qing Yang · NCT07177742
Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Phase N/A · 1 location(s) · Helse Stavanger HF · NCT01762813
Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06848842
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
EARLY_Phase 1 · 1 location(s) · Northwell Health · NCT07172282
Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer
NA · 1 location(s) · Oslo University Hospital · NCT03494946
DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
Phase 3 · 1 location(s) · Tehran University of Medical Sciences · NCT06555003
Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 1/Phase 2 · 12 location(s) · HepaRegeniX GmbH · NCT06638502
The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases
NA · 1 location(s) · Jules Bordet Institute · NCT07109440
Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT07310537
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 · 2 location(s) · Daping Hospital and the Research Institute of Surgery of the · NCT06848465
Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases
NA · 1 location(s) · Institut Investigacio Sanitaria Pere Virgili · NCT04520737
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
Phase N/A · 9 location(s) · Sirtex Medical · NCT05967143
Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Phase 2 · 41 location(s) · UNICANCER · NCT06475352
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · 12 location(s) · MacroGenics · NCT06242470
Selective Internal Radiation Therapy With 90Y Resin Micropheres for Refractory Colorectal Cancer Liver Metastases
Phase N/A · 1 location(s) · Aarhus University Hospital · NCT04491929
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Phase 2 · 1 location(s) · National Cancer Centre, Singapore · NCT04912765
Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases
Phase 1 · 1 location(s) · West China Hospital · NCT06545630
A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM
Phase 2 · 1 location(s) · Shanghai 6th People's Hospital · NCT06590259
Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration
NA · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06126419
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Phase N/A · 1 location(s) · Shengjing Hospital · NCT06208397
FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07467434
TheraSphere Japan Pre-Market Study
NA · 4 location(s) · Boston Scientific Corporation · NCT07377487
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04668872
Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis
NA · 1 location(s) · Anton Skaro · NCT05884723
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
Phase 1 · 1 location(s) · Changhai Hospital · NCT05240950
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
Phase 1/Phase 2 · 1 location(s) · M.R. Meijerink · NCT06630624
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.